Ferrex 150none

Minerals

Brand: Breckenridge Pharmaceutical

CapsuleMineralOn Market
Click to view full label

Net Contents

100 Unit Dose Capsule(s)

Serving Size

1–2 Capsule(s)

Servings Per Container

100

Supplement Form

Capsule

Bar Code (UPC/SKU)

3 51991 20311 7

Product Version

11749-05-20

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

1Active Ingredients

Single-ingredient formula listed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

1% Daily Value Coverage

1 ingredients report a %DV; 1 meet or exceed 100% DV.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1–2 Capsule(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Iron(Polysaccharide-Iron)150 mg833%

Not Present

Other Ingredients

Sodium Lauryl SulfateGelatinStearic AcidPolyethylene GlycolMicrocrystalline CelluloseCitric AcidCroscarmellose SodiumTitanium DioxidePolyvinylpyrrolidoneFD&C Yellow #5 LakeFD&C Red #40 LakeFD&C Red #3 LakeFD&C Blue #1 Lake

Target Groups

Adult (18 - 50 Years)

Label Claims

All OtherApproved HealthStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

Indication and Usage Ferrex 150 may be used for the dietary management of iron deficiencies.

Suggested/Recommended/Usage/Directions

Dosage and Administration Usual adult dosage is one or two capsules daily, or as directed by a physician or health-care provider. Do not exceed recommended dosage.

Warnings & Precautions

Precautions re: All Other

Do not use if blister seals are broken

Precautions re: Allergies

Contraindications Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product.

Precautions re: All Other

Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement.

Precautions re: Allergies

Precautions This product contains FD&C Yellow No. 5 Lake (Tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 Lake (Tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.

Precautions re: All Other

The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systematic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible.

Precautions re: Children

As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning.

Precautions re: All Other

Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools.

Precautions re: Pregnant or Nursing or Prescription Medications

Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other.

Precautions re: Pregnant or Nursing or Prescription Medications

If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.

Precautions re: Children

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions re: All Other

Adverse Reactions Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient.

Precautions re: All Other

Overdosage The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Precautions re: Children

Warning: Keep this and all medications out of the reach of children.

Precautions re: All Other

To report a serious adverse event contact: 1-800-367-3395. Warning: Reproductive harm - www.P65Warnings.ca.gov.

Storage

Storage

Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP controlled room temperature. Protect from light and moisture.

Formulation

Formula re: Contains

Ferrex 150 Polysaccharide-Iron Complex Capsules are a product of ferric iron complexed to a low molecular weight polysaccharide.

Formula re: Contains

Polysaccharide-Iron Complex Capsules

FDA Statements

FDA Statement of Identity

Dietary Supplement

FDA Statement of Identity

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Other Label Statements

General Statements: All Other Content

51991-203-11

General Statements: All Other Content

How Supplied Ferrex 150 Capsules are supplied as orange/brown capsules, imprinted “B203”. Each blister contains 10 capsules per card, 51991-203-11.

General Statements: All Other Content

All substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Manufacturer & Distributor

Manufacturer

Contract Pharmacal Corp.

Hauppauge, NY, 11788

Distributor

Breckenridge Pharmaceutical, Inc.

Berlin, CT, 06037

1-800-367-3395

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2020-07-23. DSLD Label ID: 230127. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.